Landmark clinical trial shows promise in quest for HIV vaccine
|
A successful HIV vaccine will likely require at
least three components aimed at distinct viral regions. |
New strategy targets rare B cells for effective HIV vaccine development
... epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus ( HIV ). View article...